Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2021-06-27 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于股东完成非交易过户的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the completion of non-trade share transfers among shareholders of the company. It details the transfer of shares from two dissolved investment partnerships to individual partners, including specific share quantities and percentages of total share capital. It also clarifies that these transfers do not affect the controlling shareholder or the company's governance structure. The document is a formal disclosure of shareholding changes but does not report financial results, management changes, or other types of filings. It is not a report itself but an announcement of shareholding changes through non-trade transfers. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or shareholding structure changes.
2021-06-27 Chinese
关于控股股东、实际控制人控制的合伙企业完成非交易过户暨权益变动的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding changes in shareholding due to a non-trade transfer of shares controlled by the company's controlling shareholder and actual controller. It details the increase and decrease in shareholding percentages, the method of transfer (non-trade transfer due to dissolution of partnership enterprises), and confirms that the controlling shareholder remains the same. The document includes specific shareholding numbers, dates, and regulatory compliance statements. It does not contain financial statements or detailed financial performance data. The content fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2021-06-27 Chinese
关于公司产品拟中选第五批全国药品集中采购的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the proposed selection of a product in the fifth batch of national centralized drug procurement. It includes details about the product, its pricing, and the potential impact on the company. The document is short (1016 characters) and serves as a notification of a business event rather than a financial report or detailed filing. It does not contain financial statements, audit information, or regulatory certifications. It is an announcement about a business development related to product procurement and market impact, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2021-06-24 Chinese
关于董事、高级管理人员股份减持计划实施完成的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by a director/senior management member (庞国强) of the company. It details the shareholding before and after the reduction, confirms compliance with relevant securities laws and regulations, and states that the reduction plan has been fully implemented. This type of document is a report of personal share transactions by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is short and focused solely on this topic, with no financial statements or other report content.
2021-06-23 Chinese
关于公司大股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company disclosing the pledge of shares by a major shareholder. It details the number of shares pledged, the pledgee, the purpose, and other related information. There is no financial statement, earnings data, or management discussion. The document is short (1571 characters) and serves as a regulatory disclosure about share pledge, which is a capital/financing activity. Therefore, it fits best under Capital/Financing Update (CAP).
2021-06-23 Chinese
关于公司大股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a major shareholder of the company. It details the number of shares pledged, the pledgee, the purpose, and other related information. There is no financial statement, report, or detailed analysis present. The document is short (1570 characters) and serves as a disclosure of a capital-related event (share pledge). This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share pledges.
2021-06-18 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.